Abstract
Aims
In this retrospective study, we evaluated the role of 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in differentiating malignant from benign portal vein thrombosis (PVT) in patients with known malignant tumors.
Methods
Seventy-two patients with histologically or clinically confirmed PVT and who had undergone 18F-FDG PET/CT were included. Visual and semiquantitative analyses of PET/CT scans were performed. Metabolic activity was measured using the maximum standardized uptake value (SUVmax) by drawing the region of interest at the site of thrombosis. Receiver operating characteristic analysis was conducted to identify the optimal cutoff of SUVmax for detecting neoplastic thrombosis. Malignancy was defined using the following criteria: (1) visual analysis and (2) SUVmax >3.35. PET/CT results were confirmed with histopathological results and clinical and imaging follow-up.
Results
The SUVmax of tumor thrombus (6.37 ± 2.67) was significantly higher than that of bland thrombus (2.87 ± 1.47; P < 0.01). The sensitivities, specificities, and accuracies for the two criteria were 91.5 % and 93.6; 64.0 and 80.0 %; and 81.9 % and 88.9 %, respectively.
Conclusion
18F-FDG PET/CT is a promising new method for distinguishing between portal venous neoplastic thrombosis and bland thrombosis using semiquantitative analysis, with the optimal cutoff value of SUVmax >3.35 as a criterion.
Similar content being viewed by others
References
Sotiropoulos GC, Radtke A, Schmitz KJ, et al. (2008) Liver transplantation in the setting of hepatocellular carcinoma and portal vein thrombosis: a challenging dilemma? Dig Dis Sci 53(7):1994–1999
Sizemore AW, Jacobs MP, Mantil JC, Hahm GK (2007) FDG uptake in inferior vena cava tumor thrombus from renal cell carcinoma on positron emission tomography. Clin Nucl Med 32(4):309–311
Gupta P, Kramer EL, Ponzo F (2005) FDG uptake in tumor thrombus in inferior vena cava from rectal cancer on positron emission tomography. Clin Nucl Med 30(5):342–343
Kaida H, Ishibashi M, Kurata S, Uchida M, Hayabuchi N (2007) Tumor thrombus in the inferior vena cava from colon cancer detected by 18F-FDG–PET. Ann Nucl Med 21:185–188
Nguyen BD (2005) Pancreatic neuroendocrine tumor with portal vein tumor thrombus: PET demonstration. Clin Nucl Med. 30:628–629
Kurtovic J, Van Der Wall H, Riordan SM (2005) FDG PET for discrimination between tumor extension and blood thrombus as a cause for portal vein thrombosis in hepatocellular carcinoma: important role in exclusion of transplant candidacy. Clin Nucl Med 30(6):408–410
Hanajiri K, Mitsui H, Maruyama T, et al. (2005) 18F-FDG PET for hepatocellular carcinoma presenting with portal vein tumor thrombus. J Gastroenterol 40:1005–1006
Tateishi U, Yamaguchi U, Terauchi T, et al. (2005) Extraskeletal osteosarcoma: extensive tumor thrombus on fused PET–CT images. Ann Nucl Med 19(8):729–732
Strobel K, Steinert HC, Bhure U, et al. (2007) Tumour thrombus in the superior vena cava from anaplastic carcinoma of the thyroid: FDG–PET/CT imaging findings. Eur J Nucl Med Mol Imaging 34:813
Lai P, Bomanji JB, Mahmood S, et al. (2007) Detection of tumour thrombus by 18F FDG–PET/CT imaging. Eur J Cancer Prev 16:90–94
Davidson T, Goitein O, Avigdor A, Zwas ST, Goshen E (2009) 18F-FDG–PET/CT for the diagnosis of tumor thrombosis. Isr Med Assoc J 11:69Y73
Sharma P, Kumar R, Jeph S, et al. (2011) 18F-FDG PET–CT in the diagnosis of tumor thrombus: can it be differentiated from benign thrombus? Nucl Med Commun 32:782–788
Lee EY, Khong PL (2013) The value of 18F-FDG PET/contrast-enhanced CT in detection of tumor thrombus. Clin Nucl Med 38(2):60–65
Sun L, Guan YS, Pan WM, et al. (2008) Highly metabolic thrombus of the portal vein: 18F fluorodeoxyglucose positron emission tomography/computer tomography demonstration and clinical significance in hepatocellular carcinoma. World J Gastroenterol 14(8):1212–1217
Connolly GC, Chen R, Hyrien O, et al. (2008) Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res 122(3):299–306
Takizawa D, Kakizaki S, Sohara N, et al. (2007) Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis. Dig Dis Sci 52:3290–3295
Alswat KA, Sanai FM, Altuwaijri M, et al. (2013) Clinical characteristics of patients with hepatocellular carcinoma in a middle eastern population. Hepat Mon 13(5):e7612
Kaufman LB, Yeh BM, Breiman RS, et al. (2005) Inferior vena cava filling defects on CT and MRI. Am J Roentgenol 185:717–726
Aslam Sohaib SA, Teh J, Nargund VH, et al. (2002) Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging. J Urol 167:1271–1275
Ergen FB, Hussain HK, Caoili EM, et al. (2004) MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. Am J Roentgenol 182:217–225
Spritzer CE, Trotter P, Sostman HD (1998) Deep venous thrombosis: gradient-recalled-echo MR imaging changes over time—experience in 10 patients. Radiology 208(3):631–639
Aurangabadkar HU, Palle L, Ali Z (2013) Tumour thrombosis and patterns of fluorine-18 fluorodeoxyglucose uptake: a pictorial review. Nucl Med Commun 34:627–637
Ichiki M, Sakai Y, Nango M, et al. (2012) Experimental venous thrombi: MRI characteristics with histopathological correlation. Br J Radiol 85(1012):331–338
Zhuang H, Alavi A (2002) 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 32(1):47–59
Do B, Mari C, Biswal S, et al. (2006) Diagnosis of aseptic deep venous thrombosis of the upper extremity in a cancer patient using F-18 FDG PET/CT. Ann Nucl Med 20:151–155
Miceli M, Atoui R, Walker R, et al. (2004) Diagnosis of deep septic thrombophlebitis in cancer patients by F-18 FDG positron emission tomography scanning: a preliminary report. J Clin Oncol 22:1949–1956
Probst S, Seltzer A, Chachoua A, Friedman K (2010) Azygos venous tumor thrombus from renal cell carcinoma detected by F-18 FDG PET/CT. Clin Nucl Med. 35:832–833
Ozülker T, Ozülker F, Eker O, Ozpaçaci T, Ozcan D (2009) Tumour thrombus from follicular thyroid cancer detected by 18F-FDG–PET/CT. Hell J Nucl Med 12:66–67
Sun L, Wu H, Pan W-M, Guan Y-S (2007) Positron emission tomography/computed tomography with (18)F-fluorodeoxyglucose identifies tumor growth or thrombosis in the portal vein with hepatocellular carcinoma. World J Gastroenterol 13:4529–4532
Shimoda M, Iso Y, Tomita S, et al. (2008) Middle bile duct cancer with portal vein tumor thrombus. World J Surg Oncol 6:48
Beadsmoore J, Cheow K, Sala E, et al. (2005) Hepatocellular carcinoma tumor thrombus in a re-canalised para-umbilical vein: detection by 18-fluoro-2-deoxyglucose positron emission tomography imaging. Br J Radiol 78:841–844
Kikuchi M, Yamamoto E, Shiomi Y, et al. (2004) Internal and external jugular vein thrombosis with marked accumulation of FDG. Br J Radiol 77:888–890
Acknowledgments
This study was supported by the National Nature Science Foundation of China, No. 81170435 and the Shanghai Leading Talent Team Construction Special Funds, No. 2011-036.
Conflict of interest
There are no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Additional information
Each author had participated sufficiently in the study. Publication is approved by all authors, the work was carried out in Shanghai Changhai Hospital.
Rights and permissions
About this article
Cite this article
Hu, S., Zhang, J., Cheng, C. et al. The role of 18F-FDG PET/CT in differentiating malignant from benign portal vein thrombosis. Abdom Imaging 39, 1221–1227 (2014). https://doi.org/10.1007/s00261-014-0170-5
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-014-0170-5